Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The landscape of spine surgery has undergone a transformative shift with the widespread adoption of minimally invasive spine (MIS) surgery. This revolutionary approach to spinal procedures is characterized by smaller incisions, reduced muscle disruption, and quicker recovery times compared to traditional open surgeries. The benefits associated with MIS surgery include faster recovery time, less postoperative pain, reduced risk of muscle damage, and a lower chance of surgical site infection or complications. The surge in popularity of MIS surgery is evident in the increasing adoption rates, with a remarkable growth from 1.8% to 15.1% between 2012 and 2018. This surge is driven by technological advancements in MIS techniques and a growing preference for minimally invasive procedures among patients and healthcare professionals.
One of the most notable advantages of minimally invasive spine surgery is the significantly faster recovery time it offers compared to traditional open surgeries. The smaller incisions and reduced muscle trauma associated with MIS procedures allow patients to experience shorter hospital stays and quicker return to normal activities. This swift recovery not only contributes to improved patient satisfaction but also reduces the economic burden on healthcare systems by minimizing hospital resources and postoperative care requirements.
Less postoperative pain is another key benefit that sets MIS surgery apart from traditional approaches. The minimally invasive nature of these procedures results in reduced tissue trauma, leading to less pain during the recovery period. This is a critical factor in enhancing the overall patient experience, as reduced pain levels contribute to improved quality of life post-surgery. Patients undergoing MIS surgery often require less pain medication, further minimizing the risk of opioid-related complications, a prevalent concern in the current healthcare landscape.
The risk of muscle damage is significantly lower in MIS surgery compared to traditional open procedures. In traditional surgeries, extensive muscle dissection is often necessary to access the surgical site, leading to increased trauma and potential damage to surrounding tissues. In contrast, MIS surgery involves targeted approaches that minimize disruption to adjacent muscles and tissues. This reduced muscle damage not only contributes to a speedier recovery but also preserves the structural integrity of the spine, minimizing the risk of long-term complications.
The lower chance of surgical site infection or complications is a crucial aspect of MIS surgery that enhances patient safety. The smaller incisions reduce the exposure of the surgical site to external contaminants, lowering the risk of infections. Additionally, the precision offered by advanced imaging technologies in MIS procedures contributes to fewer complications during and after surgery. This emphasis on minimizing the risk of postoperative complications aligns with the broader goals of improving patient outcomes and reducing the overall healthcare burden.
The remarkable growth in the adoption of minimally invasive procedures, from 1.8% to 15.1% between 2012 and 2018, reflects the increasing acceptance and recognition of the benefits offered by MIS surgery. This shift is driven by a combination of factors, including patient preferences, advancements in surgical techniques, and a growing body of evidence supporting the efficacy of MIS procedures. Patients are increasingly seeking alternatives that offer faster recovery, less pain, and lower risks, contributing to the rise in demand for MIS surgery.
Technological advancements in minimally invasive spine surgery play a pivotal role in shaping the landscape of spinal procedures. Innovations such as robotic-assisted surgery, advanced imaging modalities, and specialized instrumentation have significantly enhanced the precision and efficacy of MIS procedures. These technologies empower surgeons with greater control and visibility during surgery, contributing to improved patient outcomes and expanding the scope of conditions that can be effectively treated through MIS approaches.
The rising preference for minimally invasive procedures is poised to be a driving force behind the expansion of the MIS market. Patients are increasingly informed and proactive in their healthcare decisions, and many are opting for procedures that offer the benefits of MIS surgery. This shift in patient preferences is complemented by a growing pool of surgeons trained in MIS techniques, further facilitating the widespread adoption of minimally invasive approaches.
As the MIS market continues to expand, there are opportunities for further innovation and refinement of techniques. Continued research and development in MIS technologies, coupled with ongoing training programs for healthcare professionals, will contribute to the sustained growth of the MIS market. The collaborative efforts of industry stakeholders, including surgeons, medical device manufacturers, and regulatory bodies, will be crucial in navigating challenges and ensuring the responsible and effective integration of MIS procedures into mainstream healthcare practices.
In conclusion, the rise of minimally invasive spine surgery represents a transformative shift in the field of spinal procedures. The numerous benefits, including faster recovery time, less postoperative pain, reduced risk of muscle damage, and a lower chance of complications, position MIS surgery as a preferred choice for both patients and healthcare professionals. The remarkable growth in adoption rates from 2012 to 2018 underscores the increasing recognition of the advantages offered by MIS procedures. With ongoing technological advancements and a growing preference for minimally invasive approaches, the MIS market is poised for continued expansion, contributing to improved patient outcomes and shaping the future of spinal surgery.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Segment Outlook | Type, Product, Application, and End User |
Bioelectric Medicine Market Highlights:
Global Bioelectric Medicine Market Overview
Bioelectric Medicine Market size was valued at USD 21.81 Billion in 2022 and is projected to grow from USD 23.87 Billion in 2023 to USD 53.80 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.53% during the forecast period (2023 - 2032).
Increasing incidences of chronic diseases across the globe and rising strategic initiatives by market players are the major factors driving the growth of the Bioelectric Medicine Market. As per the World Health Organization, 18 million people were suffering from rheumatoid arthritis in 2019, of which 70% were women and 55% were older than 55 years. Moreover, Crohn’s & Colitis UK suggested that one in every 123 people in the UK will have had either Crohn’s disease or ulcerative colitis in 2022. However, the high cost associated with bioelectric medicine devices is expected to restrain the growth of the global market. Nevertheless, increasing clinical trials for bioelectric medicine and rising investment in bioelectric medicine by market players are anticipated to create lucrative opportunities for the market.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Bioelectric Medicine Trends
- Increasing Incidences of chronic diseases across the globe fuels market growth
The increasing incidences of chronic diseases across the globe are contributing significantly to the growth of bioelectric medicine. Chronic diseases, such as chronic pain conditions, neurological disorders, inflammatory diseases, and metabolic disorders, impose a substantial burden on healthcare systems and adversely impact patients' quality of life. Traditional treatment approaches, including pharmaceuticals and surgeries, may offer limited efficacy or pose risks of adverse effects for some patients. The increasing incidence of diseases and bioelectric medicine's promising application in these conditions is creating huge demand for bioelectric medicine products. For example, deep brain stimulation (DBS) has shown efficacy in managing the symptoms of Parkinson's disease by regulating abnormal neuronal activity. Similarly, neuromodulation devices like vagus nerve stimulation (VNS) have demonstrated benefits in reducing seizure frequency in patients with epilepsy. Moreover, in February 2024, the World Health Organization reported that around 50 million people worldwide were suffering from epilepsy, and nearly 80% of people with epilepsy live in low- and middle-income countries.
Bioelectric Medicine Segment Insights
Bioelectric Medicine Product Insights
The global bioelectric medicine segmentation, based on product, includes implantable cardioverter defibrillators, cardiac pacemakers, cochlear implants, spinal cord stimulators, deep brain stimulators, transcutaneous electrical nerve stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. The implantable cardioverter defibrillators segment held the largest market and deep brain stimulators is the fastest growing segment during the forecast period. Implantable cardioverter defibrillators dominate the market segment primarily because of their superior accuracy and shorter battery lifespan. Deep brain stimulators deliver electric signals to specific areas of brain to help regulate the brain activity. DBS has shown significant effectiveness in treating various neurological and movement disorders such as Parkinson's disease, essential tremor, dystonia, and obsessive-compulsive disorder. As more research demonstrates its efficacy, more clinicians are turning to DBS as a viable treatment option.
Figure 2: Bioelectric Medicine Market, by Product, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Bioelectric Medicine Type Insights
The bioelectric medicine market segmentation, based on type, into implantable electroceutical devices and non-invasive electroceutical devices. The implantable electroceutical devices segment held the largest market and non-invasive electroceutical devices is the fastest growing segment during the forecast period. With the rise in chronic diseases and the aging population, the implantable electroceutical device has emerged as the leading choice. This is primarily due to its ability to deliver targeted electric stimulation to specific areas with high accuracy, meeting the increasing demand and ultimately enhancing patient outcomes. Non-invasive electroceutical devices typically do not involve surgical procedures or invasive techniques, reducing the associated risks and potential side effects. This makes them more appealing to both patients and healthcare providers. With Continuous advancements in technology have led to the development of more sophisticated and effective non-invasive electroceutical devices. These devices can target specific areas of the body or brain with precision, enhancing their therapeutic efficacy.
Bioelectric Medicine Application Insights
The Bioelectric Medicine Market has been segmented, based on application into arrhythmia, pain management, sensorineural hearing loss, Parkinson’s disease, tremor, depression, epilepsy, urinary, and fecal incontinence, others. The arrhythmia segment held the largest market and sensorineural hearing loss is the fastest growing segment during the forecast period. The major reason being increase in prevalence of arrhythmia. The high prevalence of arrhythmias drives the demand for medical devices designed to diagnose, monitor, and treat these conditions. According to National Library of Medicine the prevalence of arrhythmias is expected to be 1.5% to 5% in the general population, with atrial fibrillation being the most common. Arrhythmias may or may not produce any symptoms and can be paroxysmal, leading to difficulty in estimating true prevalence. The overall presence of arrhythmia is associated with higher morbidity and mortality. The sensorineural hearing loss segment is the fastest-growing segment during the forecast period, due to increasing prevalence, technological innovations, awareness, accessibility, and regulatory support.
Bioelectric Medicine End User Insights
Based on end user, the market has been segmented into hospitals, research institutes, and others. The hospitals segment held the largest market and research institutes is the fastest growing segment during the forecast period. Hospitals serve as primary healthcare centers where a wide range of medical procedures, treatments, and surgeries are conducted, including the use of medical devices. They have the infrastructure, skilled healthcare professionals, and resources necessary to diagnose, treat, and manage various medical conditions, driving the demand for medical devices in these settings. research institutes segment is the fastest-growing segment during the forecast period due to increasing investments in healthcare research and development. Research institutes play a crucial role in advancing medical science, developing innovative technologies, and conducting clinical trials to evaluate the safety and efficacy of new medical devices. The rising emphasis on scientific exploration, coupled with collaborations between research institutions and industry players, fuels the growth of this segment as it contributes to the development of cutting-edge medical devices and therapies.
Bioelectric Medicine Regional Insights
By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. North America bioelectric medicine market accounted for the largest market share of 38.01% in 2022 and is anticipated to reach approximately USD 16.00 billion by 2032 at a 4.71% CAGR during the forecast period. However, Asia-Pacific is projected to grow at the highest CAGR of 8.99% during the forecast period.
The outlook for the North America bioelectric medicine market remains promising, with sustained growth anticipated. Investments in healthcare infrastructure and a growing awareness of advanced medical solutions are expected to drive market expansion further. Both established players and emerging entrants are poised to capitalize on these opportunities, leveraging technological advancements to meet the rising demand for improved surgical outcomes.
Further, the major countries will be study are US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: BIOELECTRIC MEDICINE MARKET BY REGION 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe bioelectric medicine market accounted for the second-largest market share due to technology advancements, increasing healthcare expenditure, and increasing prevalence of chronic diseases. Furthermore, the Germany bioelectric medicine market attributed to hold the largest market share, and the France bioelectric medicine market projected be the fastest growing market in the Europe region.
The Asia-Pacific bioelectric medicine market is expected to be the fastest growing from 2023 to 20302 owing to high patient population, rising prevalence of chronic diseases, and favorable regulatory policies. Moreover, key players working in the market are actively expanding into this region, further driving the regional market growth. Moreover, China bioelectric medicine market accounted to hold the largest market share, and the India bioelectric medicine market projected to be the fastest growing market in the Asia-Pacific region.
Bioelectric Medicine Key Market Players & Competitive Insights
The Bioelectric Medicine Market is characterized by the presence of many global, regional, and local players. Developments in the healthcare industry and growing research and development make the bioelectric medicine market lucrative. To expand their reach and optimize their operational costs, the major players focus on obtaining regulatory authorizations from government agencies for their products and emphasize product approvals and product launches to gain a substantial market share. Mergers and collaborations were also observed to expand the company's product portfolio, as well as introduce new products. The growth of prominent industry players is dependent on various factors, such as market conditions, government support, and industry development. The major players have adopted a strategy of obtaining regulatory approval from government agencies for their products and signing contracts and agreements to broaden their reach and reduce operational costs.
For instance, Abbott i a global healthcare company that operates in various segments, including medical devices, diagnostics, nutrition, and pharmaceuticals. With respect to bioelectric medicine, Abbott has made significant contributions and advancements in this field through its Neuromodulation division.
In July 2023, Abbott announced the U.S. Food and Drug Administration (FDA) approved the AVEIR dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms.
Key Companies Bioelectric Medicine in market includes.
- Abbott (US)
- Boston Scientific Corporation (US)
- Biotronik (Germany)
- Aleva Neurotherapeutics (Switzerland)
- Cochlear Ltd. (Australia)
- LivaNova PLC (UK)
- Medtronic (Ireland)
- Charco Neurotech (UK)
- ElectroCore, Inc. (US)
- Nevro Corp (US)
Bioelectric Medicine Industry Developments
- January 2024, The US, the FDA has approved Medtronic's Percept RC Deep Brain Stimulation (DBS) system. Percept RC is the thinnest and smallest dual channel neurostimulator for DBS available right now. It is equipped with Brain Sense technology, which records and analyzes brain activity to provide information that enables a physician to adapt treatment to a patient's evolving requirements.
- February 2023, LivaNova PLC launched the SenTiva DUO implantable pulse generator for epilepsy. The device is designed to provide VNS therapy for drug-resistant epilepsy treatment.
- December 2022, ElectroCore, Inc. unveiled Truvaga, a New Wellness Product Offering for Stress, Anxiety, and Sleep, to its US-based clientele. Truvaga is a portable, non-invasive vagus nerve stimulator that stimulates the vagus nerve quickly and gently using our tried-and-true technology.
- April 2019, Biotronik introduced an implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D), Acticor and Rivacor CRT-D and ICD devices in Europe. Its goal is to reduce the need for device replacements, hence lowering risks, reducing patient suffering, and saving money on operations.
Bioelectric Medicine Segmentation
Bioelectric Medicine Product Outlook
- Implantable Cardioverter Defibrillators
- Cardiac Pacemakers
- Cochlear Implants
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Transcutaneous Electrical Nerve Stimulators
- Sacral Nerve Stimulators
- Vagus Nerve Stimulators
- Others
Bioelectric Medicine Type Outlook
- Implantable Electroceutical Devices
- Non-invasive Electroceutical Devices
Bioelectric Medicine Application Outlook
- Arrhythmia
- Pain Management
- Sensorineural Hearing Loss
- Parkinson’s Disease
- Tremor
- Depression
- Epilepsy
- Urinary and Fecal Incontinence
- Others
Bioelectric Medicine End User Outlook
- Hospitals
- Research Institutes
- Others
Bioelectric Medicine Regional Outlook
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
